Cited 0 time in
Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jo, Kyung-Wook | - |
| dc.contributor.author | Yoon, Young Soon | - |
| dc.contributor.author | Kim, Hyung Woo | - |
| dc.contributor.author | Kim, Joong-Yub | - |
| dc.contributor.author | Kang, Young Ae | - |
| dc.date.accessioned | 2025-03-05T01:43:18Z | - |
| dc.date.available | 2025-03-05T01:43:18Z | - |
| dc.date.issued | 2025-01 | - |
| dc.identifier.issn | 1738-3536 | - |
| dc.identifier.issn | 2005-6184 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/57843 | - |
| dc.description.abstract | Latent tuberculosis infection (LTBI) is characterized by immune responses to Mycobacterium tuberculosis antigens without clinical symptoms or evidence of active tuberculosis. Effective LTBI management is crucial for tuberculosis elimination, requiring accurate diagnosis and treatment. In South Korea, LTBI guidelines have been updated periodically, the latest being in 2024. This review discusses the recent changes in the Korean guideline for the diagnosis and treatment of LTBI in adults. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한결핵및호흡기학회 | - |
| dc.title | Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4046/trd.2024.0122 | - |
| dc.identifier.scopusid | 2-s2.0-85214422548 | - |
| dc.identifier.wosid | 001383520700002 | - |
| dc.identifier.bibliographicCitation | Tuberculosis and Respiratory Diseases, v.88, no.1, pp 56 - 68 | - |
| dc.citation.title | Tuberculosis and Respiratory Diseases | - |
| dc.citation.volume | 88 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 56 | - |
| dc.citation.endPage | 68 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART003150090 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Respiratory System | - |
| dc.relation.journalWebOfScienceCategory | Respiratory System | - |
| dc.subject.keywordPlus | ISONIAZID PREVENTIVE THERAPY | - |
| dc.subject.keywordPlus | TREATMENT COMPLETION | - |
| dc.subject.keywordPlus | ADVERSE EVENTS | - |
| dc.subject.keywordPlus | FOLLOW-UP | - |
| dc.subject.keywordPlus | RIFAPENTINE | - |
| dc.subject.keywordPlus | RIFAMPIN | - |
| dc.subject.keywordPlus | TRIAL | - |
| dc.subject.keywordPlus | TB | - |
| dc.subject.keywordPlus | REGIMENS | - |
| dc.subject.keywordPlus | IMPACT | - |
| dc.subject.keywordAuthor | Latent Tuberculosis Infection | - |
| dc.subject.keywordAuthor | Diagnosis | - |
| dc.subject.keywordAuthor | Treatment | - |
| dc.subject.keywordAuthor | Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
